Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration


SIZMAZ S., ESEN E., Isik-Ericek P., Demircan N.

CLINICAL AND EXPERIMENTAL OPTOMETRY, vol.105, no.1, pp.55-60, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 105 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.1080/08164622.2021.1896334
  • Journal Name: CLINICAL AND EXPERIMENTAL OPTOMETRY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.55-60
  • Keywords: Aflibercept, central macular thickness, neovascular age-related macular degeneration, ranibizumab, subfoveal choroidal thickness
  • Çukurova University Affiliated: Yes

Abstract

Background: The aim of this study is to analyse the real-world outcome of vascular endothelial growth factor blocking agents in neovascular age-related macular degeneration.